Life Science

We invest across all stages of development and have backed portfolio companies as diverse as Ventritex, Rinat Neurosciences, Cadence Pharmaceuticals, and Revance Therapeutics. We have a broad Life Science Portfolio with particular focused efforts within neurotechnology, cost-effective medicine, and consumer medicine.

Select Life Science Portfolio

Benvenue Medical
Benvenue Medical is focused on Advancing Spine Repair® through the design, manufacture, and marketing of innovative medical devices for use in minimally invasive spinal therapies.

BrainCells is developing novel therapies for affective and cognitive disorders based on proprietary neurogenesis technology.

Cadence Pharmaceuticals
Acquired by Mallinckrodt Pharmaceuticals (NYSE: MNK)
Cadence Pharmaceuticals (formerly NASDAQ: CADX) is a specialty pharmaceutical company focused on developing an IV formulation of acetaminophen for the management of peri-operative pain.


Calypte Biomedical (AMEX: HIV)
Calypte Biomedical Corporation is a provider of diagnostic testing solutions for HIV, STDs, and other chronic diseases.


Cardax Pharmaceuticals (OTCBB: CDXI)
Cardax Pharmaceuticals is developing proprietary drugs to reduce oxidative stress and inflammation. The lead compound is focused on preventing neurological damage and rethrombosis in stroke patients.


Cell Pathways
Acquired by OSI Pharmaceuticals (NASDAQ: OSIP)
Cell Pathways (formerly NASDAQ: CLPA) developed drugs that induce selective apoptosis (programmed cell death) in precancerous and cancerous cells for the prevention and treatment of colon and lung cancers.


Cereve is a consumer-oriented medical device company targeted at the treatment of sleep disorders.

Aquired by Inverness Medical (NYSE:IMA)
Cholestech (formerly NASDAQ: CTEC) is a leading provider of diagnostic devices and information for point-of-care diagnostic testing for cholesterol and related lipids, blood glucose and glycemic control, inflammation and liver enzymes.
  Corcept Therapeutics (NASDAQ:CORT)
Corcept Therapeutics is a pharmaceutical company involved in the development and commercialization of drugs that regulate the effect of cortisol (the stress hormone).

Aquired by Boston Scientific (NYSE:BSX)
CryoCor (formerly NASDAQ: CRYO) is developing cryo-ablation devices for the minimally invasive treatment of atrial fibrillation and other cardiac arrhythmias.


Aquired by American Medical Systems (NASDAQ:AMMD)
Cryogen produces low-temperature surgical devices for the women's health market.


Acquired by BTG International (LSE:BTG)
Ekos develops ultrasound-enabled drug delivery devices for the treatment of stroke and peripheral applications.

Eneura (formerly Neuralieve) is a medical technology company developing a hand-held device for the treatment of migraine headache. Neuralieve's core technology is based on the science of transcranial magnetic stimulation (TMS).

Elcelyx Therapeutics
Elcelyx Therapeutics is a privately-held Consumer Medicine company focused on creating a wide range of products based on the science of nutrient sensing.


Essentialis is a clinical-stage pharmaceutical company targeted at obesity and other metabolic disorders.


ForSight VISION5
Acquired by Allergan (NYSE: AGN)
ForSight VISION5 developing therapies targeting Ophthalmological disorders.

Acquired by Percardia
HeartStent is a medical device company targeted at the treatment of coronary artery disease.
  Incline Therapeutics
Acquired by The Medicines Company (NASDAQ: MDCO)
Incline is a drug-device company targeted as post-operative patient-controlled analgesia.
Innercool Therapies

Aquired by Phillips (NYSE:PHG)
Innercool Therapies is the leader in therapeutic hypothermia devices to protect the brain from further injury following stroke, cardiac arrrest or brain surgery.
Aquired by Intercell (VSX:ICLL)
Iomai (formerly NASDAQ:IOMI) is developing vaccines delivered via a novel, needle-free technology. The company's clinical-stage programs include seasonal flu, traveler's diarrhea and pandemic flu.
  Iridex (NASDAQ:IRIS)
Iridex manufactures and markets light-based medical systems and delivery devices for multiple specialties including Aesthetic Medicine, Ophthalmology, and Otolaryngology.
  Leptos Biomedical 
Aquired by St. Jude Medical (NYSE:STJ)

Leptos Biomedical is developing a proprietary neuromodulation therapy for obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system.
Medwave manufactures and markets a non-invasive monitoring system for measuring blood pressure.
NeuroPace is developing fully- implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy.
  Nfocus Neuromedical
Aquired by Covidien (NYSE:COV)
NFocus is developing novel neurovascular devices for the treatment of cerebral aneurysms and hemorrhagic stroke.
Aquired by Medtronic (NYSE:MDT)
Percusurge was the pioneer in developing emboli-protection devices for the prevention of stoke and heart attack.
  Revance Therapeutics (NASDAQ:RVNC)
ReVance Therapeutics is a specialty pharmaceutical company focused on aesthetic dermatology.
  Rinat Neuroscience
Acquired by Pfizer (NYSE:PFE)
Rinat is developing novel therapies based on anti-body technology for the treat of CNS disorders.
  Saegis Pharmaceuticals
Acquired by Lundbeck Pharmaceuticals (OMX:LUN)
Saegis develops therapies for the treatment of Alzheimer's Disease and other memory disorders.
Acquired by Amicus (NASDAQ: FOLD)
Scioderm is focused on the development of innovative drugs for the treatment of chronic diseases of the skin.
  Solta Medical (NASDAQ:SLTM)
Solta Medical is producing and marketing non-invasive devices to tighten and contour skin, utilizing a proprietary combination of radio frequency energy and surface cooling technology.
  Spinal Dynamics
Aquired by Medtronic (NYSE:MDT)
Spinal Dynamics develops neuro-surgical devices for the replacement of spinal disks.
  TONIX Pharmaceuticals (NASDAQ:TNXP)
TONIX Pharmaceuticals is focusing on drugs for the Central Nervous System. The Company is currently developing new treatments for fibromyalgia and post-traumatic stress disorder.
  Transcend Medical
Acquired by Novartis (NYSE:NVS)
Transcend Medical is focused on the research and development of novel devices for the treatment of glaucoma.

Tria Beauty
Tria Beauty is a medical device company focused on bringing light-based dermatologic therapies into the home.

Acquired by St. Jude Medical (NYSE:STJ)
Ventritex (formerly NASDAQ: VNTX) was a pioneer in the development of implantable defibrillators for the treatment of ventricular tachycardia and fibrillation.
Acquired by Abbott (NYSE:ABT)
Visiogen is developing the next generation of accommodating intraocular lens (IOL) for cataract surgery.
Latest News and Events
Corcept Therapeutics: Cushing's Syndrome Is Just The Beginning
Vision 5 Acquisition:
Allergan Bought Itself an Exciting Opportunity in ForSight
Transcend FDA Approval of CyPass:
Alcon achieves US approval for CyPass® Micro-Stent, a micro invasive surgical device to treat glaucoma
Transcend Acquisition: Alcon Makes Big Move in MIGS
Scioderm Acquisition - Rubbing allantoin's lamp:
Amicus Scioderm buyout worth as much as $847M

Elcelyx Raises $40M, Begins Late-Stage Trial of New Diabetes Drug

Jim Glasheen Chairman of Recent Consumer Medicine Summit:

2nd Annual CBC Financial Summit: Meritocracy, The Industry Spin and Aesthetics - Making Sense of the Global Aesthetic Market

Roger Quy to speak at The Neurotech Industry Investing & Partnering Conference:

Copyright© 2008 - 2012 Technology Partners. All rights reserved. SITE MAP